OmanDocSign in

Curriculum · Metabolic and Endocrine and Diabetes Mellitus

Approach to thyroid function testing

What it is

Thyroid testing runs in a fixed order. Define the clinical picture first, hypo, hyper or euthyroidal. Then look at the TFTs. Then screen the antibodies: anti-TPO, anti-TSHr and anti-TG. Thyroglobulin is kept for thyroidectomy patients, to rule out other causes of hyperthyroidism, since it will be suppressed. Then decide the trajectory, US neck against nuclear imaging, and nuclear imaging is only indicated in biochemically hyperthyroid patients. Then ask whether tissue sampling is needed. The final question is whether to treat and how: medical, radiation, or interventional and surgical.

How it is diagnosed

For a goiter, diffuse or nodular, measure TSH first.

If suspicious features are present, do a fine needle aspiration biopsy; if not, monitor. A thyroid ultrasound is not obtained routinely in Hashimoto's thyroiditis, and is reserved for larger goiters, thyroid asymmetry, or a concern for thyroid nodularity.

How it is treated

Numbers from a laboratory authorising guideline are worth keeping. Not on treatment: a TSH below 0.1 mU/L is more likely to be subclinical hyperthyroidism in primary care and NTI in hospital; an fT4 above 19 pmol/L there is hyperthyroid and, if the patient is not on thyroxine, is referred to the endocrine team, while a normal fT4 means adding fT3, and both an fT3 above 5.7 pmol/L, which suggests hyperthyroidism, and a normal fT3 carry a referral to the endocrine team. A TSH of 0.1-0.4 mU/L means adding fT4 and fT3, with a repeat in 1 month if fT3 is increased with toxic symptoms, and a repeat that depends on clinical symptoms if fT4 and/or fT3 are normal. A TSH of 5-10 mU/L means repeating in 3 months with TPO antibodies, though TPO antibodies are not suggested in those over 65; TPO antibodies high are then monitored annually, TPO antibodies low are monitored 3 yearly. A TSH above 10 mU/L with an fT4 below 9 pmol/L is hypothyroid; with an fT4 of 9-11 pmol/L it is mild thyroid failure, repeated in 3 months to confirm; and with an fT4 of 11-19 pmol/L it is repeated in 3 months after excluding NTI and drugs. On treatment with thyroxine: aim for a TSH of 0.4-2 mU/L with fT4 in the upper 1/3 of the reference range. A TSH below 0.1 mU/L suggests the patient is over-treated with thyroxine, unless the patient has hypopituitarism, while it is a TSH below 0.01 mU/L that is over-treated with thyroxine and is appropriate if post-thyroidectomy for thyroid cancer. A TSH above 5 mU/L suggests the patient is under replaced if the dose has run 8 weeks or longer with full compliance, while a high fT4 alongside it raises erratic compliance. Allow a minimum of 8 weeks for TSH to stabilise after a dose is started or changed, and suspect assay interference with any unusual pattern. A low fT4 without a rise in TSH means adding prolactin, FSH, LH, oestradiol or testosterone, and cortisol, with referral to the endocrine team if the results suggest hypopituitarism.